IFN-γ derived from immunotherapy-activated CD8+T cells and radiotherapy-activated ataxia telangiectasia mutated (ATM) can independently or synergistically suppress the expression of SLC7A11 to reduce cystine uptake, enhance tumor lipid oxidation and ferroptosis, and improve tumor control. This evidence concerns the gene CD8A and neoplasm.